XML 69 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Details) - Schedule of segment information - Parent [Member] - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Sale of medical equipment      
Abdominal CPR Compression $ 301,549 $ 58,750 $ 221,414
Mobile Medicine (sleep apnea diagnostic products) 21,776 153,644 120,930
Provision of OSAS diagnostic services 35,211 171,064 217,042
Total net revenues 358,536 383,458 559,386
Cost of revenue      
Sale of medical equipment (275,465) (112,942) (464,918)
Provision of OSAS diagnostic services (371,188) (630,802) (292,983)
Total cost of revenue (646,653) (743,744) (757,901)
Gross loss      
Sale of medical equipment 47,860 99,452 (122,574)
Provision of OSAS diagnostic services (335,977) (459,738) (75,941)
Total gross loss (288,117) (360,286) (198,515)
Depreciation and amortization expense:      
Sale of medical equipment 7,006 84,371 535,800
Provision of OSAS diagnostic services 444,878 693,746 291,830
Total depreciation and amortization expenses 451,884 778,117 827,630
Capital expenditure      
Sale of medical equipment 16,137
Provision of OSAS diagnostic services 760,191
Total capital expenditure $ 776,328